These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13662106)

  • 1. Preliminary institutional evaluation of a new drug in cerebral palsy: N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (soma).
    PHELPS WM
    Arch Pediatr (N Y); 1959 Jun; 76(6):243-50. PubMed ID: 13662106
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary trial of a new muscle relaxant; nisopropyl-2-methyl-2-propyl-1,3 propanediol dicarbamate (soma) in outpatient children with cerebral palsy.
    SPEARS CE; PHELPS WM
    Arch Pediatr (N Y); 1959 Jul; 76(7):287-92. PubMed ID: 13662111
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of cerebral palsy with akineton].
    WALLIS H
    Monatsschr Kinderheilkd (1902); 1957 Sep; 105(9):334-7. PubMed ID: 13517089
    [No Abstract]   [Full Text] [Related]  

  • 4. Methocarbamol as a muscle relaxant: its clinical evaluation in acute trauma and chronic neurological states.
    CARPENTER EB
    South Med J; 1958 May; 51(5):627-30. PubMed ID: 13556167
    [No Abstract]   [Full Text] [Related]  

  • 5. Soma: normal hematopoletic response to hematinics during the administration of N-isopropyl-2-methyl-2-propyl-1, 3-propanediol dicarbamate.
    BARNARD RD; BILLOW BW
    Harlem Hosp Bull (N Y); 1960 Mar; 1():68-71. PubMed ID: 13796855
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative assessment of motor function in cerebral palsy; evaluation of zoxazolamine (flexin), a new muscular relaxant drug.
    HADRA R; MILLICHAP JG
    Neurology; 1956 Dec; 6(12):843-52. PubMed ID: 13378587
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of resyl as an adjunct in the treatment of cerebral palsy.
    NEWMAN MK; PENDY GV; GOLDSTEIN AS; KATZEN GD
    Am J Phys Med; 1956 Jun; 35(3):160-9. PubMed ID: 13327026
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of zoxazolamine (flexin) in children with cerebral palsy.
    WATKINS M; HALE MH
    J Am Med Assoc; 1957 Oct; 165(7):830-3. PubMed ID: 13462857
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).
    SELLING LS
    J Am Med Assoc; 1955 Apr; 157(18):1594-6. PubMed ID: 14367012
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of carisoprodol in cerebral palsy].
    PHELPS WM
    Prensa Med Mex; 1960; 25():481-3. PubMed ID: 13735242
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.
    BORRUS JC
    J Am Med Assoc; 1955 Apr; 157(18):1596-8. PubMed ID: 14367013
    [No Abstract]   [Full Text] [Related]  

  • 12. Carisoprodol (soma); muscle relaxant properties in children with cerebral palsy.
    ARGY WP
    Georgetown Med Bull; 1960 May; 13():198-200. PubMed ID: 13794192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parpanit and artane as pediatric antispasmodics].
    MELIN KA; HERRLIN KM
    Nord Med; 1952 Mar; 47(10):312-4. PubMed ID: 14911006
    [No Abstract]   [Full Text] [Related]  

  • 14. Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.
    Prescrire Int; 2008 Dec; 17(98):237. PubMed ID: 19422149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of meprobamate (Miltown) in convulsive and related disorders.
    PERLSTEIN MA
    J Am Med Assoc; 1956 Jul; 161(11):1040-4. PubMed ID: 13331757
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary clinical trial of carisoprodol in infantile cerebral palsy.
    WOODS GE
    Dev Med Child Neurol; 1962 Feb; 4():28-34. PubMed ID: 14008240
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrathecal baclofen in the management of spasticity due to cerebral palsy.
    Vloeberghs M; Keetley R; Morton R
    Pediatr Rehabil; 2005; 8(3):172-9. PubMed ID: 16087551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of cerebral palsy with chlormethazanone].
    HANSEN E
    Ugeskr Laeger; 1961 Sep; 123():1353-4. PubMed ID: 13904411
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent.
    BERGER FM
    J Pharmacol Exp Ther; 1954 Dec; 112(4):413-23. PubMed ID: 13222235
    [No Abstract]   [Full Text] [Related]  

  • 20. Muscle relaxants in cerebral palsy: a comparative study. II. Chlorophenylmethylthiazanone sulfone (trancopal).
    STERLING HM
    Arch Phys Med Rehabil; 1960 Jun; 41():226-8. PubMed ID: 13834416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.